Literature DB >> 16958061

Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Bahattin Hakyemez1, Cuneyt Erdogan, Naile Bolca, Nalan Yildirim, Gokhan Gokalp, Mufit Parlak.   

Abstract

PURPOSE: To investigate the contribution of perfusion-weighted MR imaging (PWI) by using the relative cerebral blood volume (rCBV) ratio in the differential diagnosis of various intracranial space-occupying lesions.
MATERIALS AND METHODS: This study involved 105 patients with lesions (high-grade glioma (N=26), low-grade glioma (N=11), meningioma (N=23), metastasis (N=25), hemangioblastoma (N=6), pyogenic abscess (N=4), schwannoma (N=5), and lymphoma (N=5)). The patients were examined with a T2*-weighted (T2*W) gradient-echo single-shot EPI sequence. The rCBV ratios of the lesions were obtained by dividing the values obtained from the normal white matter. Statistical analysis was performed with the Mann-Whitney U-test. A P-value less than 0.05 was considered statistically significant.
RESULTS: The rCBV ratio was 5.76+/-3.35 in high-grade gliomas, 1.69+/-0.51 in low-grade gliomas, 8.02+/-3.89 in meningiomas, 5.27+/-3.22 in metastases, 11.36+/-4.41 in hemangioblastomas, 0.76+/-0.12 in abscesses, 1.10+/-0.32 in lymphomas, and 3.23+/-0.81 in schwannomas. The rCBV ratios were used to discriminate between 1) high- and low-grade gliomas (P<0.001), 2) hemangioblastomas and metastases (P<0.05), 3) abscesses from high-grade gliomas and metastases (P<0.001), 4) schwannomas and meningiomas (P<0.001), 5) lymphomas from high-grade gliomas and metastases (P<0.001), and 6) typical meningiomas and atypical meningiomas (P<0.01).
CONCLUSION: rCBV ratios can help discriminate intracranial space-occupying lesions by demonstrating lesion vascularity. It is possible to discriminate between 1) high- and low-grade gliomas, 2) hemangioblastomas and other intracranial posterior fossa masses, 3) abscesses from high-grade gliomas and metastases, 4) schwannomas and meningiomas, 5) lymphomas and high-grade gliomas and metastases, and 6) typical and atypical meningiomas. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16958061     DOI: 10.1002/jmri.20707

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  61 in total

Review 1.  Imaging of skull base pathologies: Role of advanced magnetic resonance imaging techniques.

Authors:  Ankit Mathur; Narendra Jain; C Kesavadas; Bejoy Thomas; T R Kapilamoorthy
Journal:  Neuroradiol J       Date:  2015-10-01

2.  Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Z Xing; R X You; J Li; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2013-08-31       Impact factor: 3.649

3.  MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status.

Authors:  K Yamashita; A Hiwatashi; O Togao; K Kikuchi; R Hatae; K Yoshimoto; M Mizoguchi; S O Suzuki; T Yoshiura; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

Review 4.  Imaging of cerebellopontine angle lesions: an update. Part 2: intra-axial lesions, skull base lesions that may invade the CPA region, and non-enhancing extra-axial lesions.

Authors:  Fabrice Bonneville; Julien Savatovsky; Jacques Chiras
Journal:  Eur Radiol       Date:  2007-06-14       Impact factor: 5.315

Review 5.  Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.

Authors:  A Romano; M C Rossi Espagnet; L F Calabria; V Coppola; L Figà Talamanca; V Cipriani; G Minniti; A Pierallini; L M Fantozzi; A Bozzao
Journal:  Radiol Med       Date:  2011-09-02       Impact factor: 3.469

6.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

7.  Lateral ventricle haemangioblastoma: the role of perfusion scanning and embolisation in diagnosis and management.

Authors:  Ian Anderson; Ramesh Kumar; Tufail Patankar; Atul Tyagi
Journal:  BMJ Case Rep       Date:  2014-09-25

Review 8.  MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma.

Authors:  Simona Gaudino; Matia Martucci; Rosellina Russo; Emiliano Visconti; Emma Gangemi; Francesco D'Argento; Tommaso Verdolotti; Libero Lauriola; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2016-10-18       Impact factor: 1.475

9.  Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.

Authors:  J Cha; S T Kim; D-H Nam; D-S Kong; H-J Kim; Y K Kim; H Y Kim; G M Park; P Jeon; K H Kim; H S Byun
Journal:  Clin Neuroradiol       Date:  2016-03-07       Impact factor: 3.649

10.  Local Glioma Cells Are Associated with Vascular Dysregulation.

Authors:  S G Bowden; B J A Gill; Z K Englander; C I Horenstein; G Zanazzi; P D Chang; J Samanamud; A Lignelli; J N Bruce; P Canoll; J Grinband
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.